Cite
HARVARD Citation
McGrane, J. et al. (2021). The Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Cancer. Clinical oncology. 33 (1), pp. e92-. [Online].